Patient Social Support Influential Factor for Transplant Providers

Share this content:
Patient Social Support Influential Factor for Transplant Providers
Patient Social Support Influential Factor for Transplant Providers

FRIDAY, July 20, 2018 (HealthDay News) -- For transplant providers, the second most influential factor determining a patient's suitability for transplantation is social support, according to a report published online June 28 in the Journal of Medical Ethics.

Keren Ladin, Ph.D., from Tufts University of Medford, Mass., and colleagues examined how transplant providers weigh the important of social support for kidney recipients. A total of 584 transplant providers who responded to the National Survey of the American Society of Transplant Surgeons and the Society of Transplant Social Work in 2016 compared two hypothetical patient profiles and selected one for transplantation. The relative importance of each factor was estimated.

The researchers found that the second most influential factor among transplant providers was social support. Providers were most likely to choose a candidate with social support, who always adhered to a medical regimen, and who had a life expectancy of 15 years with transplant (odds ratios, 1.68, 1.64, and 1.61, respectively). Compared with medical/surgical providers, psychosocial providers were more influenced by adherence and quality of life; medical/surgical providers were more influenced by life expectancy with transplant. Social support was the most influential factor for providers concerned with avoiding organ waste, while it was the least influential factor for clinicians concerned with fairness.

"Social support is highly influential in listing decisions and may exacerbate transplant disparities," the authors write. "Providers' beliefs and reliance on social support in determining suitability vary considerably, raising concerns about transparency and justice."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »